fda warning letters glp-1 compounded september 2025 takes aim at Hims & Hers, weight loss drugs in new advertising blitz CDER Warning Letters Jump 50%

Simplifies Reconstitution Peptide reconstitution often confuses beginners

PepsiCo CEO Ramon Laguarta mentioned GLP-1s for the first time in two years in the companys earnings call Tuesday

1 Novo Nordisk continues to pursue innovative delivery models and strategic collaborations to meet people where they are, reaching more patients in more ways

Are these medications a long-term solution

However, any post-surgical peptide use should be discussed with and approved by your operating surgeon

4 Cascade catalytic nanoreactor Integrating nanotechnology, catalytic chemistry, and biomedicine has led to the development of cascade catalytic nanoreactors, representing an advanced strategy for preventing and treating oral infectious diseases